A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
The human gut microbiome has been associated with many health factors but variability between studies limits the exploration of effects between them. This study aims to systematically characterize the gut microbiota of various critical chronic diseases, compare the similarities and differences of the microbiome signatures linked to different regions and diseases, and further investigate their impacts on microbiota-based diagnostic models.
Many studies demonstrate that microbial dysbiosis has been linked to many human pathologies. However, the current understanding of the identification of the disease-associated microbiome signatures remains limited, largely owing to the heterogeneity of microbial community structures which are shaped by the host. Undoubtedly, profiles of microbial biomarkers require validation in large, independent, population-based cohorts from different districts. Based on these, the investigator plan to organize a multicentric cross-sectional cohort, not only to systematically characterize the gut microbiota of various critical chronic diseases, such as liver cancer, gastric cancer, pancreatic cancer, lung cancer, nasopharyngeal cancer, hypertension, acute coronary syndrome, primary aldosteronism, epilepsy, chronic kidney disease, and subclinical hypothyroidism but also to compare the similarities and differences of the microbiome signatures linked to different regions and different diseases and to further investigate their impacts on microbiota-based diagnostic models. In this study, for each kind of disease, the investigators expect to recruit 500 patients with a confirmed diagnosis and 500 sex- and age-matched controls, to record their information related to demography, body measurement, lifestyle, diet, medication, diseases, and biochemistry, and to collect their feces, saliva, urine and blood samples.
Inclusion Criteria:
Exclusion Criteria:
zjh13049139791@163.com13049139791
Chaoyang, Beijing Municipality 100028, China
13693568626
Nanchuan, Chongqing Municipality 408400, China
Yongchuan, Chongqing Municipality 402177, China
Foshan, Guangdong 528200, China
Guangzhou, Guangdong 510600, China
Shenzhen, Guangdong 518107, China
Nanning, Guangxi 530007, China
Tongliao, Guangxi 543002, China
13481411516
Guiyang, Guizhou 550001, China
Daqing, Heilongjiang 163316, China
Harbin, Heilongjiang 150007, China
Harbin, Heilongjiang 150088, China
Qiqihar, Heilongjiang 161005, China
Luoyang, Henan 471003, China
Xianyang, Hubei 441599, China
15871057798
Wuzhou, Inner Mongolia 028000, China
15247519335
Nanchang, Jiangx 330000, China
Binhai, Tianjin Municipality 300270, China
13132181211
Dayingmen, Tianjin Municipality 300060, China
Kashgar, Xinjiang Uygur Autonomous Region 844000, China
13996856392
13504549189
13365910806
13600807079
13905010494
13919300448
13919309189
13106598603
18903078510
18002295130
18898389835
13737089977
13878813926
18786126238
18985111828
13337600255
13304690977
13796029276
15545545606
13763665650
15904526839
13939926329
13837988831
13937057566
18108650781
15207275328
13873381276
13861740103
13807968267
15279799667
13576041466
15935530258
13700514558
13934151016
13363963035
15102813601
15308287599
15608139066
18622221306
18630922553
18909981658
13808706308
13988901090
13566017561